Nimesulida Baldacci (Nimesulide)

Nimesulide selectively blocks the cyclooxygenase‑2 (COX‑2) enzyme, which converts arachidonic acid into prostaglandins that drive inflammation, pain and fever. By inhibiting COX‑2 while sparing COX‑1, it lowers prostaglandin levels at inflamed sites, providing analgesic and anti‑inflammatory effects with comparatively less gastric irritation than non‑selective NSAIDs.

The dosage regimen for Nimesulida Baldacci is determined by the prescribing clinician based on the patient’s condition, age, renal and hepatic function, and concomitant therapies. The prescriber will specify the strength, frequency and duration appropriate for each individual case.

Safety data for nimesulide in pregnancy and lactation are limited, and the drug is generally avoided unless the potential benefit outweighs the risk. Healthcare providers should assess each situation carefully and consider alternative therapies that have established safety profiles for pregnant or nursing mothers.

To request Nimesulida Baldacci, submit an enquiry on the product page at gnhindia.com, indicating the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with non‑selective NSAIDs such as ibuprofen or diclofenac, nimesulide offers more selective COX‑2 inhibition, which may reduce the incidence of gastric irritation. However, it carries its own risk profile, including potential liver toxicity, and should be chosen based on individual patient factors and clinical judgment.

Nimesulida Baldacci tablets should be stored at ambient temperature, preferably below 25 °C, in their original blister pack or container to protect from moisture and light. Keep the product out of reach of children and do not use after the expiry date.

The medication is taken orally, usually with a full glass of water. It may be taken with or without food, although taking it with meals can help minimise gastrointestinal discomfort. Patients should follow the dosing instructions provided by their prescriber.

The most serious adverse events include hepatotoxicity, which can manifest as elevated liver enzymes or severe liver injury, and severe allergic reactions such as anaphylaxis or Stevens‑Johnson syndrome. Prompt medical attention is required if signs of liver dysfunction or severe skin reactions occur.

Nimesulida Baldacci is contraindicated in individuals with known hypersensitivity to nimesulide or other NSAIDs, patients with active peptic ulcer disease, severe hepatic impairment, and those taking anticoagulants where bleeding risk is unacceptable. It should also be avoided in pregnant women unless clearly indicated by a physician.